Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Viridian Therapeutics, Inc. (VRDN) had Debt to Capital Ratio of 0.03 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.07M |
|
$-86.91M |
|
-- |
|
$0.07M |
|
$93.94M |
|
$-93.87M |
|
$6.95M |
|
$-86.91M |
|
$-86.91M |
|
$-86.91M |
|
$-86.91M |
|
$-86.91M |
|
$-86.91M |
|
$-93.87M |
|
$-95.97M |
|
81.34M |
|
81.34M |
|
$-0.87 |
|
$-0.87 |
|
| Balance Sheet Financials | |
$657.24M |
|
$1.16M |
|
$3.74M |
|
$660.98M |
|
$33.73M |
|
$20.68M |
|
$22.78M |
|
$56.51M |
|
$415.59M |
|
$604.47M |
|
$604.47M |
|
81.59M |
|
| Cash Flow Statement Financials | |
$-92.65M |
|
$100.06M |
|
$9.21M |
|
$99.59M |
|
$116.22M |
|
$16.62M |
|
$10.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.49 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.03 |
0.03 |
|
100.00% |
|
-130369.50% |
|
-130369.50% |
|
-- |
|
-120711.10% |
|
-120711.10% |
|
$-92.74M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-20.91% |
|
-14.38% |
|
-13.15% |
|
-13.90% |
|
$7.41 |
|
$-1.14 |
|
$-1.14 |
|